AMNEAL PHARMACEUTICALS, INC. (AMRX) Shares outstanding analysis
- Shares outstanding · latest quarter: Value 319.35M; Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 1 year ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 5 years ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares change · vs previous quarter: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
Shares outstanding analysis
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Shares outstanding · latest quarter | 319.35M | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 1 year ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 5 years ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
| Shares count change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current quarter shares | 319.35M shares | |
| Previous quarter shares | (m) |
Shares means common shares outstanding, adjusted to the same split basis for comparison. It is a count, not USD or convertible securities; B means billion shares.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current quarter shares (shares) | Shares count change · vs previous quarter | Shares change (%) · vs previous quarter |
|---|---|---|---|
| 2026-06-30 | 319.35M | (m) | (m) |
| 2026-03-31 | 319.02M | (m) | (m) |
| 2025-12-31 | 314.63M | (m) | (m) |
| 2025-09-30 | 314.36M | (m) | (m) |
| 2025-06-30 | 314.08M | (m) | (m) |
| 2025-03-31 | 313.42M | (m) | (m) |
| 2024-12-31 | 309.97M | (m) | (m) |
| 2024-09-30 | 309.84M | (m) | (m) |
| 2024-06-30 | 309.54M | (m) | (m) |
| 2024-03-31 | 308.65M | (m) | (m) |
| 2023-12-31 | 307.01M | (m) | (m) |
| 2023-09-30 | 306.54M | (m) | (m) |
| 2023-06-30 | 154.19M | (m) | (m) |
| 2023-03-31 | 153.34M | (m) | (m) |
| 2022-12-31 | 151.50M | (m) | (m) |
| 2022-09-30 | 151.48M | (m) | (m) |
| 2022-06-30 | 151.41M | (m) | (m) |
| 2022-03-31 | 150.81M | (m) | (m) |
| 2021-12-31 | 149.42M | (m) | (m) |
| 2021-09-30 | 149.37M | (m) | (m) |
| 2021-06-30 | 149.28M | (m) | (m) |
| 2021-03-31 | 148.72M | (m) | (m) |
| 2020-12-31 | 147.70M | (m) | (m) |
| 2020-09-30 | 147.63M | (m) | (m) |
| 2020-06-30 | 147.54M | (m) | (m) |
| 2020-03-31 | 147.31M | (m) | (m) |
| 2019-12-31 | 147.11M | (m) | (m) |
| 2019-09-30 | 134.10M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |